Expression profile of genes involved in pathogenesis of pediatric Crohn's disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 6, 2012, Pages 1083-1093

  Sim, Winnie H ^a   Wagner, Josef ^a   Cameron, Donald J ^b   Catto Smith, Anthony G ^b   Bishop, Ruth F ^a   Kirkwood, Carl D ^a  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Crohn's disease; Gene expression profiling; Microbiology; Pediatric; Virology

Indexed keywords

MESSENGER RNA;

ADOLESCENT; ANPEP GENE; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL INFECTION; CELL CYCLE; CELL PROLIFERATION; CHILD; CONNECTIVE TISSUE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; EXTRACELLULAR MATRIX; FEMALE; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEUM; INFECTION; INFLAMMATION; INTESTINE BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MMP2 GENE; MOLECULAR CLONING; NEOPLASM; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REG1A GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEQUENCE ANALYSIS; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; UPREGULATION; VIRUS INFECTION;

EID: 84861470518     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06973.x     Document Type: Article

References (65)

1. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006; 3: 390-407.
2. Franke A, McGovern DP, Barrett JC etal. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 2010; 42: 1118-25.
3. Van Limbergen J, Wilson DC, Satsangi J. The genetics of Crohn's disease. Annu. Rev. Genomics Hum. Genet. 2009; 10: 89-116.
4. Hugot JP, Laurent-Puig P, Gower-Rousseau C etal. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821-3.
5. Kugathasan S, Baldassano RN, Bradfield JP etal. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat. Genet. 2008; 40: 1211-15.
6. Glocker EO, Kotlarz D, Boztug K etal. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 2009; 361: 2033-45.
7. Relman DA. New technologies, human-microbe interactions, and the search for previously unrecognized pathogens. J. Infect. Dis. 2002; 186 (Suppl. 2): S254-8.
8. Carey R, Jurickova I, Ballard E etal. Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease. Inflamm. Bowel Dis. 2008; 14: 446-57.
9. Costello CM, Mah N, Hasler R etal. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med. 2005; 2: e199.
10. Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol. Genomics 2000; 4: 1-11.
11. Dooley TP, Curto EV, Reddy SP etal. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm. Bowel Dis. 2004; 10: 1-14.
12. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum. Mol. Genet. 2001; 10: 445-56.
13. Noble CL, Abbas AR, Lees CW etal. Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis. Inflamm. Bowel Dis. 2010; 16: 1717-28.
14. Wu F, Dassopoulos T, Cope L etal. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm. Bowel Dis. 2007; 13: 807-21.
15. Diatchenko L, Lau YF, Campbell AP etal. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl Acad. Sci. U.S.A. 1996; 93: 6025-30.
16. Chang Y, Cesarman E, Pessin MS etal. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
17. Hadjiargyrou M, Lombardo F, Zhao S etal. Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J. Biol. Chem. 2002; 277: 30177-82.
18. Pan YS, Lee YS, Lee YL, Lee WC, Hsieh SY. Differentially profiling the low-expression transcriptomes of human hepatoma using a novel SSH/microarray approach. BMC Genomics 2006; 7: 131; doi: 10.1186/1471-2164-7-131.
19. Silverberg MS, Satsangi J, Ahmad T etal. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can. J. Gastroenterol. 2005; 19 (Suppl. A): 5-36.
20. Wagner J, Sim WH, Ellis JA etal. Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort. PLoS ONE 2010; 5: e15376.
21. Diehn M, Sherlock G, Binkley G etal. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res. 2003; 31: 219-23.
22. Rhead B, Karolchik D, Kuhn RM etal. The UCSC genome browser database: update 2010. Nucleic Acids Res. 2010; 38: D613-19.
23. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 2000; 132: 365-86.
24. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29: e45.
25. Garg P, Rojas M, Ravi A etal. Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis. J. Immunol. 2006; 177: 4103-12.
26. Delmas B, Gelfi J, L'Haridon R etal. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 1992; 357: 417-20.
27. Breslin JJ, Mork I, Smith MK etal. Human coronavirus 229E: receptor binding domain and neutralization by soluble receptor at 37 degrees C. J. Virol. 2003; 77: 4435-8.
28. Barnich N, Carvalho FA, Glasser AL etal. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J. Clin. Invest. 2007; 117: 1566-74.
29. Akula SM, Pramod NP, Wang FZ, Chandran B. Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 2002; 108: 407-19.
30. Beswick EJ, Bland DA, Suarez G, Barrera CA, Fan X, Reyes VE. Helicobacter pylori binds to CD74 on gastric epithelial cells and stimulates interleukin-8 production. Infect. Immun. 2005; 73: 2736-43.
31. Zhang JQ, Wang JJ, Li WJ etal. Cellular protein TTRAP interacts with HIV-1 integrase to facilitate viral integration. Biochem. Biophys. Res. Commun. 2009; 387: 256-60.
32. Stoddard E, Ni H, Cannon G etal. gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue. J. Virol. 2009; 83: 8596-603.
33. Xu Y, Kulkosky J, Acheampong E, Nunnari G, Sullivan J, Pomerantz RJ. HIV-1-mediated apoptosis of neuronal cells: proximal molecular mechanisms of HIV-1-induced encephalopathy. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 7070-5.
34. Johnson EM, Doyle JD, Wetzel JD etal. Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis. J. Virol. 2009; 83: 9630-40.
35. Moriuchi M, Moriuchi H, Fauci AS. HTLV type I Tax activation of the CXCR4 promoter by association with nuclear respiratory factor 1. AIDS Res. Hum. Retroviruses 1999; 15: 821-7.
36. Knas M, Choromanska M, Karaszewska K etal. Activity of lysosomal exoglycosidases in saliva of patients with HIV infection. Adv. Med. Sci. 2007; 52: 186-90.
37. Sikora D, Greco-Stewart VS, Miron P, Pelchat M. The hepatitis delta virus RNA genome interacts with eEF1A1, p54(nrb), hnRNP-L, GAPDH and ASF/SF2. Virology 2009; 390: 71-8.
38. Mori Y, Koike M, Moriishi E etal. Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic 2008; 9: 1728-42.
39. Bolt G. The measles virus (MV) glycoproteins interact with cellular chaperones in the endoplasmic reticulum and MV infection upregulates chaperone expression. Arch. Virol. 2001; 146: 2055-68.
40. Lopez-Herrera A, Liu Y, Rugeles MT, He JJ. HIV-1 interaction with human mannose receptor (hMR) induces production of matrix metalloproteinase 2 (MMP-2) through hMR-mediated intracellular signaling in astrocytes. Biochim. Biophys. Acta 2005; 1741: 55-64.
41. Wex T, Kuester D, Vieth M etal. Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (alpha1-PI) levels in antral mucosa and peripheral blood. Scand. J. Gastroenterol. 2008; 43: 1194-201.
42. Raineri I, Senn HP. HIV-1 promotor insertion revealed by selective detection of chimeric provirus-host gene transcripts. Nucleic Acids Res. 1992; 20: 6261-6.
43. Kerr JR, Kaushik N, Fear D, Baldwin DA, Nuwaysir EF, Adcock IM. Single-nucleotide polymorphisms associated with symptomatic infection and differential human gene expression in healthy seropositive persons each implicate the cytoskeleton, integrin signaling, and oncosuppression in the pathogenesis of human parvovirus B19 infection. J. Infect. Dis. 2005; 192: 276-86.
44. Ciborowski P, Kadiu I, Rozek W etal. Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome. Virology 2007; 363: 198-209.
45. Vieira MA, Gomes TA, Ferreira AJ, Knobl T, Servin AL, Lievin-Le Moal V. Two atypical enteropathogenic Escherichia coli strains induce the production of secreted and membrane-bound mucins to benefit their own growth at the apical surface of human mucin-secreting intestinal HT29-MTX cells. Infect. Immun. 2010; 78: 927-38.
46. Hauber HP, Goldmann T, Vollmer E etal. LPS-induced mucin expression in human sinus mucosa can be attenuated by hCLCA inhibitors. J. Endotoxin Res. 2007; 13: 109-16.
47. Gingras AC, Sonenberg N. Adenovirus infection inactivates the translational inhibitors 4E-BP1 and 4E-BP2. Virology 1997; 237: 182-6.
48. Canani RB, De Marco G, Passariello A etal. Inhibitory effect of HIV-1 Tat protein on the sodium-D-glucose symporter of human intestinal epithelial cells. AIDS 2006; 20: 5-10.
49. Bonderoff JM, Larey JL, Lloyd RE. Cleavage of poly(A)-binding protein by poliovirus 3C proteinase inhibits viral internal ribosome entry site-mediated translation. J. Virol. 2008; 82: 9389-99.
50. Terada Y, Yasuda Y. Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145. Mol. Cell. Biol. 2006; 26: 8149-58.
51. Sijts A, Sun Y, Janek K etal. The role of the proteasome activator PA28 in MHC class I antigen processing. Mol. Immunol. 2002; 39: 165-9.
52. Mosoian A, Teixeira A, High AA etal. Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages. J. Virol. 2006; 80: 9200-6.
53. Almarri A, Batchelor JR. HLA and hepatitis B infection. Lancet 1994; 344: 1194-5.
54. Esteban R, Vega L, Fujimura T. 20S RNA narnavirus defies the antiviral activity of SKI1/XRN1 in Saccharomyces cerevisiae. J. Biol. Chem. 2008; 283: 25812-20.
55. Bania J, Gatti E, Lelouard H etal. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs. Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 6664-9.
56. Riese RJ, Wolf PR, Bromme D etal. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996; 4: 357-66.
57. Keely S, Glover LE, MacManus CF etal. Selective induction of integrin beta1 by hypoxia-inducible factor: implications for wound healing. FASEB J. 2009; 23: 1338-46.
58. Sekikawa A, Fukui H, Fujii S etal. Possible role of REG Ialpha protein in ulcerative colitis and colitic cancer. Gut 2005; 54: 1437-44.
59. Astrosini C, Roeefzaad C, Dai YY, Dieckgraefe BK, Jons T, Kemmner W. REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis. Int. J. Cancer 2008; 123: 409-13.
60. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 357-9.
61. Baugh MD, Perry MJ, Hollander AP etal. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 1999; 117: 814-22.
62. Stallmach A, Chan CC, Ecker KW etal. Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis. Gut 2000; 47: 415-22.
63. Ravi A, Garg P, Sitaraman SV. Matrix metalloproteinases in inflammatory bowel disease: boon or a bane? Inflamm. Bowel Dis. 2007; 13: 97-107.
64. Shinozaki S, Nakamura T, Iimura M etal. Upregulation of Reg 1alpha and GW112 in the epithelium of inflamed colonic mucosa. Gut 2001; 48: 623-9.
65. Ishii T, Wallace AM, Zhang X etal. Stability of housekeeping genes in alveolar macrophages from COPD patients. Eur. Respir. J. 2006; 27: 300-6.